Technology News and Research

RSS

NIH awards three UNC Scientists for high risk and innovative research

Three scientists from the University of North Carolina at Chapel Hill School of Medicine and the UNC Lineberger Comprehensive Cancer Center have received prestigious awards from the National Institutes of Health (NIH) aimed at encouraging "high risk" and innovative research.

24 Sep 2009

New software to be demonstrated at the International CTIA WIRELESS IT & Entertainment 2009

AuthenTec, the world’s leading provider of smart sensor based solutions, announced that it will demonstrate its newest mobile products and software, and will highlight new commercially released phones that incorporate its award-winning technology at International CTIA WIRELESS IT & Entertainment 2009 in San Diego.

24 Sep 2009

McGill University receives $17,600,000 from Canada Research Chairs program

Nineteen McGill University researchers exploring issues from biomaterials to global climate change to advanced mathematics are among the 181 newly appointed or renewed Canada Research Chairs announced September 23 by the Honourable Gary Goodyear, Minister of State (Science and Technology.)

24 Sep 2009

$Cardiogenesis sponsors educational symposium on refractory angina treatment method$

Cardiogenesis sponsors educational symposium on refractory angina treatment method

Cardiogenesis Corporation, a market leader in laser transmyocardial revascularization (TMR), today announced that it sponsored an educational symposium yesterday in conjunction with the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.

24 Sep 2009

PNNL Department of Energy researcher earns prestigious NIH Director's New Innovator Award

An analytical chemist at the Department of Energy's Pacific Northwest National Laboratory has been recognized with a National Institutes of Health Director's New Innovator Award. The award will support Wei-Jun Qian's drive to make new research and clinical diagnostic tools that are dramatically more sensitive, reliable and faster than current technologies.

24 Sep 2009

TRUEresult store brand blood glucose monitoring system more accurate than name brand products: Study

Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, today announced that a new study has shown that its TRUEresult® store brand blood glucose monitoring system is comparable to the performance of more expensive name brand systems.

24 Sep 2009

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the US Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.

24 Sep 2009

Polycom's scalable solutions for the healthcare industry

Polycom, Inc., the global leader in telepresence, video and voice communication solutions, is making it easier and more cost-effective for hospitals and other healthcare organizations to deploy and scale telehealth and telemedicine networks. Through an enhanced, highly scalable solution, Polycom allows healthcare organizations to easily and securely extend visual communication capabilities outside of their private networks to a broader group of partner hospitals, community clinics and physicians.

24 Sep 2009

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment.

24 Sep 2009

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

24 Sep 2009

Study reveals that AIR Inhaled Insulin is inferior to SC insulin

The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia

24 Sep 2009

ImThera Medical completes THN system development

ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

24 Sep 2009

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

AmeriChoice of Pennsylvania and Chester County Hospital have announced an agreement that will provide AmeriChoice Medicaid members access to the hospital’s inpatient and outpatient facilities.

24 Sep 2009

RFID asset management agreements offered by Premier Purchasing Partners

Premier Purchasing Partners, LP, today announced new agreements have taken effect in a new radio frequency identification (RFID) asset management and tracking solution category. The agreements have been awarded to AeroScout Inc. of Redwood City, Calif.; Dynamic Computer Corporation of Farmington Hills, Mich., a minority owned business enterprise; International Business Solutions Alliance, LLC of Dayton, Ohio; and Skytron of Grand Rapids, Mich.

24 Sep 2009

Guarding Hearts Alliance to protect quality care for patients suffering from heart disease

Organizations representing the vast majority of cardiologists around the country have joined forces today to preserve and protect the highest quality cardiac care available in America. Guarding Hearts Alliance is advocating to protect patient access to cardiac care in whatever Medicare changes or health care reform legislation is enacted.

24 Sep 2009

Handheld diabetic test from MSGI's Nanobeak

MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood.

24 Sep 2009

FDA endorses Covidien's REMS program for EXALGO tablets

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it presented information to members of a U.S. Food and Drug Administration (FDA) Advisory Committee on the New Drug Application and proposed Risk Evaluation and Mitigation Strategy (REMS) program for EXALGOTM (hydromorphone HCl extended release) tablets, an opioid formulation.

24 Sep 2009

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009. The release of the NavAlign™ delivery system marks the 20th anniversary of Cook’s first IVC filter and further advances the treatment of pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lungs that affects thousands of Americans annually.

24 Sep 2009

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, today announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company’s potential best-in-class therapy for dry eye, LX214 (topical mixed nanomicellar formulation of voclosporin).

24 Sep 2009

DATATRAK International signs two clinical studies

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of two worldwide studies exemplifying the versatility of the DATATRAK eClinical platform.

24 Sep 2009

Technology News and Research

NIH awards three UNC Scientists for high risk and innovative research

New software to be demonstrated at the International CTIA WIRELESS IT & Entertainment 2009

McGill University receives $17,600,000 from Canada Research Chairs program

Cardiogenesis sponsors educational symposium on refractory angina treatment method

PNNL Department of Energy researcher earns prestigious NIH Director's New Innovator Award

TRUEresult store brand blood glucose monitoring system more accurate than name brand products: Study

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

Polycom's scalable solutions for the healthcare industry

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

Study reveals that AIR Inhaled Insulin is inferior to SC insulin

ImThera Medical completes THN system development

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

RFID asset management agreements offered by Premier Purchasing Partners

Guarding Hearts Alliance to protect quality care for patients suffering from heart disease

Handheld diabetic test from MSGI's Nanobeak

FDA endorses Covidien's REMS program for EXALGO tablets

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

DATATRAK International signs two clinical studies

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News